Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Globantin

Approved

STANDARD

Globantin

Zhuhai United Laboratories (Zhongshan) Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 473734182236edf2
Company: Zhuhai United Laboratories (Zhongshan) Co., Ltd.
Type: Standard

Approval Details

Approval Id: 473734182236edf2
Drug Approval Philippines Name: Globantin
Product Name: Globantin
Registration Number: DR-XY35891
Brand Name: Globantin
Generic Name: Co-Amoxiclav
Dosage Form: Powder For Injection (Iv)
Dosage Strength: 600mg
Manufacturer: Zhuhai United Laboratories (Zhongshan) Co., Ltd.
Importer: Global Pharmatrade
Distributor: Global Pharmatrade
Issuance Date: 26 April 2024
Expiry Date: 25 May 2029
Pharmacologic Category: Antibacterial (Penicillin)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

473734182236edf2

Type

Standard

Back to Philippines FDA Approvals

Globantin - Philippines FDA Drug Approval Details